LXR-beta signalling is a key mediator in the pathogenesis of aortic valve stenosis and its prevention by saringosterol
Event: ESC Congress 2022
Topic: Lipid Metabolism, Metabolic Syndrome, Diabetes
Session: Targeting lipids and lipid-related pathways in cardiovascular disease
ESC 365 is supported by
